BURBANK, Calif., March 6, 2006 (PRIMEZONE) -- Imaging3(tm), Inc. (OTCBB:IMGG), developer of a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time, reports that the company's shares have been approved for electronic transfer by Depository Trust Corporation (DTC). DTC is the central clearing house for equity transactions in the United States.
Attaining electronic transfer eligibility means that the transfer of shares from the company's transfer agent to brokerage firms can now be accomplished electronically rather than having to ship paper certificates. Additionally, this means that the share purchase and sale transactions can now be conducted via on-line brokerage firms.
"This is another step in our growth," said Dean Janes, the company's CEO. "This streamlines our certificate transfer and issuance process, making back office processes more efficient. This also allows the on-line brokerage firms to facilitate buying and selling of our shares via their websites."
About Imaging3
Imaging3, Inc., founded in 1993, is a leading provider of advanced technology medical imaging devices. The Company has developed a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time. Because these 3D images are instantly constructed in real-time, they can be used for any current or new medical procedures in which multiple frames of reference are required to perform medical procedures on or in the human body. Visit the company's website at www.imaging3.com
Safe Harbor Statement
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the Company.